RecruitingNot ApplicableNCT07003529

Role of Inferior Colliculi in Auditory Hallucinations

Rôle Des Colliculi inférieurs Dans Les Hallucinations Auditives : étude Pilote Par Neuroimagerie


Sponsor

Centre Hospitalier Universitaire de Nīmes

Enrollment

40 participants

Start Date

Sep 12, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The neural basis of auditory hallucinations (AH) in patients with schizophrenia is poorly characterized. Functional imaging studies investigate either the "state" dimension (i.e., the measurement of changes in brain area activation at the precise moment of AH onset) or the "trait" dimension (i.e., the neural correlates of the propensity to hallucinate). A corollary of AH (particularly acoustic-verbal) is the activation of brain regions involved in the auditory perception of speech (auditory cortex). One theory is that patients with schizophrenia with AH may have a deficit in processing their internal speech (i.e., external attribution to internal verbal content). However, there is little clinical data on the specific role of the mesencephalic region of the inferior colliculi (IC) in the formation of these symptoms. Preliminary research has shown intense expression of dopamine D2 receptors, particularly on glutamatergic neurons in mouse ICs. Thus, ICs receive numerous inhibitory dopaminergic inputs, likely involved in signal optimization and modulation. The study authors hypothesize that AHs are the result of a defect in signal inhibition by the IC, which lose their function as perceptual filters.


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating the role of a brain region called the inferior colliculus in auditory hallucinations — hearing voices or sounds that aren't there — in people with schizophrenia. Researchers will use brain imaging (MRI) to compare people with schizophrenia who experience hallucinations to those who don't. This study is conducted in French. **You may be eligible if...** - You have a diagnosis of schizophrenia (per DSM-5 criteria), confirmed by a structured interview - You have had schizophrenia for 20 years or fewer - You are receiving treatment in a psychiatric unit (inpatient or outpatient) - You are able to read, write, and speak French - You are covered by a health insurance plan **You may NOT be eligible if...** - You are under legal guardianship or court protection - You have severe claustrophobia or other MRI contraindications - You are deaf (congenital or acquired) - You are at risk of suicide (per clinical assessment) - You have moderate to severe intellectual disability or neurocognitive disorders Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERUnenhanced brain MRI

Unenhanced brain MRI in five sequences: 1) T1-weighted anatomical sequences 2) Resting-state functional sequences 3) Task-based functional sequence 4) Structural sequence using Diffusion Tensor Imaging (DTI) 5) Routine magnetic resonance spectroscopy sequence


Locations(1)

CHU de Nîmes, Hôpital Universitaire Carémeau

Nîmes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07003529


Related Trials